Prescription Required.Why?
Mometasone furoate is the active ingredient.Specific formulations may contain inactive ingredients like preservatives, propellants (in inhalers), or other excipients. Always check the product label for a complete list.
Allergic rhinitis (hay fever)
Nasal polyps
Asthma (inhaled formulations only)
Atopic dermatitis (eczema) (topical formulations only)
Ryaltris Mono Nasal Spray (Mometasone Furoate) is a corticosteroid. It works by reducing inflammation in the affected area by binding to intracellular glucocorticoid receptors, suppressing the release of inflammatory mediators.
Store at room temperature, away from direct sunlight and moisture. Do not freeze. Specific storage instructions may vary depending on the formulation (e.g., nasal spray, inhaler, cream). Always refer to the product label.
Dosage depends on the specific condition, formulation, and patient factors. Always follow your doctor's instructions.
Nasal sprays are typically administered as prescribed doses in each nostril.
Inhalers require careful adherence to instructions for proper inhalation technique.
Topical creams or ointments should be applied thinly to the affected area and rubbed in gently.
Nasal dryness, burning, or irritation (nasal spray)
Rarely: Increased risk of infections, cataracts, glaucoma (with prolonged use of high doses)
Hoarseness, throat irritation (inhaler)
Skin thinning, burning, or itching (topical)
Headache
No known specific interactions, but excessive alcohol use can worsen underlying conditions.
Generally safe, unless side effects like dizziness or drowsiness occur.
Use only as directed by your doctor. Benefits must outweigh potential risks to the fetus or infant.
Dosage adjustments may be needed. Always follow your doctor's instructions.
Generally safe, but monitor for potential adverse effects in individuals with severe kidney disease.
Generally safe, but monitor for potential adverse effects in individuals with severe liver disease.
Your doctor or pharmacist
Product monograph (package insert)
